We are live on ! Find out more
MGNX icon

MacroGenics

88 hedge funds and large institutions have $64.2M invested in MacroGenics in 2025 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

517% more call options, than puts

Call options by funds: $148K | Put options by funds: $24K

15% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 26

9.84% less ownership

Funds ownership: 72.89%63.05% (-9.8%)

15% less funds holding

Funds holding: 10488 (-16)

17% less capital invested

Capital invested by funds: $77.4M → $64.2M (-$13.2M)

50% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 24

Holders
88
Holders Change
-16
Holders Change %
-15.38%
% of All Funds
1.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
30
Reduced
26
Closed
24
Calls
$148K
Puts
$24K
Net Calls
+$124K
Net Calls Change
+$174K

MGNX Hedge Fund Activity: Q4 2025 in Review

88 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q4 2025, worth a combined $64.2M — down 17% from $77.4M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of MGNX and 12 opened new positions — a net loss of 12 holders — while 26 trimmed existing stakes and 30 added.

The largest buyer was Jefferies Financial Group, opening a new position worth an estimated $2.89M. The largest seller was Bellevue Group, exiting entirely with an estimated $16.7M sold.

  • 88 institutional investors held MacroGenics (MGNX) as of Q4 2025, down from 104 in Q3 2025.
  • Funds reported $64.2M of MacroGenics stock for Q4 2025, down 17% quarter-over-quarter.
  • 12 funds opened new MacroGenics positions in Q4 2025 and 24 closed out, a net change of -12 holders.
  • The largest MacroGenics buyer in Q4 2025 was Jefferies Financial Group, an estimated $2.89M added.
  • The largest MacroGenics seller in Q4 2025 was Bellevue Group, an estimated $16.7M sold.

Based on aggregated 13F filings for Q4 2025.